-+ 0.00%
-+ 0.00%
-+ 0.00%

Zelluna ASA: Invitation to Second Quarter 2026 Results Webcast Presentation

Barchart·08/13/2026 05:00:00
Listen to the news

Oslo, Norway, 13 August 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of its second quarter 2026 results on Thursday, 20 August 2026.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.